WHO WE ARE
BRIGHT-TNBC brings together leading researchers from Romania and the Republic of Moldova to develop innovative, biomarker-guided therapeutic strategies for triple-negative breast cancer (TNBC).
Our consortium combines expertise in proteomics, molecular pathology, translational oncology, and advanced preclinical modeling to address one of the most difficult challenges in breast cancer research.
OUR RESEARCH FOCUS
The project is coordinated by the “Iuliu Hațieganu” University of Medicine and Pharmacy (UMFIH), Cluj-Napoca, Romania, in strong collaboration with the “Nicolae Testemițanu” State University of Medicine and Pharmacy (USMF-NT), Chișinău, Moldova.
Together, we aim to accelerate the development of effective, affordable treatment options through scientific excellence, data-driven innovation, and meaningful knowledge exchange between our institutions.
RESEARCH LEADERSHIP AND TEAM MEMBERS
The BRIGHT-TNBC project is powered by a cross-border team of experts in proteomics, pathology, molecular oncology, and preclinical modeling. Our leadership brings together deep scientific expertise and complementary strengths from Romania and the Republic of Moldova.
Prof. Cristina-Adela Iuga
UMFIH (RO)
Conf. Dr. Eugen Melnic
USMF-NT (MD)
Aliona Nicorici
USMF-NT (MD)
Mihaela Cozma
USMF-NT (MD)
Ximena Mureșan
UMFIH (RO)
Ioana Pralea
UMFIH (RO)
Cristian Moldovan
UMFIH (RO)
Diana Tomuleasa
UMFIH (RO)
Richard Feder
UMFIH (RO)
Andreea Ungur
UMFIH (RO)